Step 1: Concept Clarification: The inquiry seeks to identify the inaugural COVID-19 vaccine originating from indigenous development within India. "Indigenous" signifies creation and production within the nation's borders.
Step 2: Comprehensive Analysis: COVAXIN: Developed by Bharat Biotech, an Indian biotechnology firm, in partnership with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). This vaccine is entirely indigenous.
COVISHIELD: Originated from Oxford University and AstraZeneca. While manufactured in India by the Serum Institute of India, its development was not indigenous.
SPUTNIK-V: A Russian vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology.
MODERNA: An American vaccine developed by Moderna, Inc.
Consequently, COVAXIN stands as the first vaccine fully developed in India.
Step 3: Conclusion:
The first indigenous COVID-19 vaccine developed in India was COVAXIN.